# Novapump

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novapump

- Industry: Medical Devices & Equipment
- Headquarters: Jena, Germany
- Website: www.novapump.de
- Latest round: Series A (Jun 3, 2020)
- Investors on record: 3

## About

Novapump GmbH develops innovative medical technology, specializing in percutaneous right heart support systems designed for acute care situations, improving patient outcomes during critical medical events.Founded in 2012 in Jena, Germany, Novapump GmbH focuses on creating advanced cardiac support devices. The company has successfully completed 5 deals, with its most recent deal occurring on June 3, 2020. The company's strategy has remained consistent since its inception, emphasizing the development of cutting-edge medical solutions.Novapump GmbH specializes in advanced medical technology focused on percutaneous, pulsatile right heart support for acute patients. Their flagship product, the PERKAT™ RV right heart pump, operates through an innovative, self-expanding mechanism allowing for rapid implantation during medical emergencies. This device targets critical conditions such as right heart infarction, cardiogenic shock, and acute decompensated right heart failure. By enhancing the efficiency of existing heart support systems, particularly when used alongside the intra-aortic balloon pump (IABP), Novapump aims to provide a superior treatment option for healthcare providers. The company's products are primarily marketed to hospitals and healthcare institutions across Europe, with a particular focus on regions with established cardiac care facilities.The revenue model for Novapump GmbH is centered around direct sales to healthcare providers, including hospitals and specialized cardiac care centers. The company engages in B2B transactions, supplying the PERKAT™ technology as a critical component of emergency cardiac care. Clients procure these devices for acute medical situations, with purchase agreements tailored to the specific needs of healthcare institutions. While detailed pricing information for the PERKAT™ pump is not publicly available, the transaction structure typically involves direct negotiations, ensuring the product aligns with both clinical requirements and logistical considerations.In June 2020, Novapump GmbH raised an undisclosed amount of Series A funding from returning investors bm-t beteiligungsmanagement Thüringen, High-Tech Gründerfonds, and Sparkasse Jena-Saale-Holzland, among others. The funds raised will be directed towards the development of upcoming products and expansion into new markets. The company is targeting increased presence in European healthcare systems and exploring entry into additional international markets by 2023, aiming to enhance its distribution networks and operational capabilities.

## Funding rounds

- Series A, Jun 3, 2020 — High-Tech Gruenderfonds, Bm-t, Sparkasse Jena-Saale-Holzland
- Series A, Dec 14, 2015 — Bm-t, Sparkasse Jena-Saale-Holzland
- Series A, Oct 31, 2015 — Bm-t
- Series A, Jul 31, 2013 — High-Tech Gruenderfonds
- Seed, Jul 1, 2013 — High-Tech Gruenderfonds

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A
- Bm-t (https://capitalatlas.ai/funds/bm-t) — Series A
- Sparkasse Jena-Saale-Holzland — Series A